0001209191-23-021573.txt : 20230330
0001209191-23-021573.hdr.sgml : 20230330
20230330091105
ACCESSION NUMBER: 0001209191-23-021573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230329
FILED AS OF DATE: 20230330
DATE AS OF CHANGE: 20230330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOUGLAS RICHARD
CENTRAL INDEX KEY: 0001021015
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40674
FILM NUMBER: 23777406
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAXCYTE, INC.
CENTRAL INDEX KEY: 0001287098
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 522210438
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-517-5556
MAIL ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: MAXCYTE INC
DATE OF NAME CHANGE: 20040415
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-29
0
0001287098
MAXCYTE, INC.
MXCT
0001021015
DOUGLAS RICHARD
C/O MAXCYTE, INC.
9713 KEY WEST AVENUE, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
2023-03-29
4
P
0
80000
4.3185
A
100000
D
The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
/s/ Brian F. Leaf, Attorney-in-Fact
2023-03-30